Trial of Herb Yuyang Ointment to Diabetic Foot Ulcer
Launched by GUIYANG NO.1 PEOPLE'S HOSPITAL · Feb 9, 2009
Trial Information
Current as of July 25, 2025
Unknown status
Keywords
ClinConnect Summary
1. Developing a Document Retrieval strategy for clinical trials of Chinese medicine treatment of diabetic foot ulcer according to the research program(finished)
2. Selecting and Evaluating the above trials,developing a methodological quality evaluation criteria(finished)
3. extract information, verification, meta-analysis, sensitivity analysis and sub-group analysis(finished)
4. comprehensive evaluating the pros and cons evidences of traditional Chinese medicine, acupuncture and Chinese and Western combined medicine with the treatment of diabetic foot of (finished)
5. we find dress change w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • In-patient or out-patient patients diagnosed with diabetic foot ulcers
- • Gangrene or ulceration occurred more than 3 weeks
- • Over 18 years of age
- • Gender-open
- • The type of diabetes (type 1 or type 2) open
- • Patients receive a written informed consent to participate in the trial
- Exclusion Criteria:
- • Serious complications of heart, liver, lung, kidney damage
- • Malignant tumors
- • Allergy for Chinese medicine used
- • Pregnant women and breast-feeding women
About Guiyang No.1 People's Hospital
Guiyang No. 1 People's Hospital is a leading medical institution located in Guiyang, China, dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent clinical trial sponsor, the hospital is committed to conducting rigorous scientific studies that contribute to the development of new therapies and medical interventions. With a multidisciplinary team of experienced healthcare professionals and researchers, Guiyang No. 1 People's Hospital aims to enhance treatment options and improve patient outcomes across various medical fields. The hospital's strategic focus on collaboration and ethical research practices positions it as a trusted partner in the global health community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guiyang, Guizhou, China
Patients applied
Trial Officials
Li Shufa, doctor
Study Chair
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials